{"component": "definition", "props": {"groups": [{"snippet": "shall have the meaning set forth in Section 3.1 hereof.", "snippet_links": [{"key": "section-31", "type": "definition", "offset": [36, 47]}], "samples": [{"hash": "g1OxHzTk3wC", "uri": "/contracts/g1OxHzTk3wC#initial-target", "label": "Collaborative Research and License Agreement (Combichem Inc)", "score": 18.0, "published": true}, {"hash": "fhjE2GTpZhS", "uri": "/contracts/fhjE2GTpZhS#initial-target", "label": "Collaborative Research and License Agreement (Combichem Inc)", "score": 18.0, "published": true}, {"hash": "fRjoXv97KKZ", "uri": "/contracts/fRjoXv97KKZ#initial-target", "label": "Collaborative Research and License Agreement (Combichem Inc)", "score": 18.0, "published": true}], "size": 11, "hash": "2e2c13dee75e8c894db0045079156d80", "id": 1}, {"snippet": "means FVIII (factor VIII).", "snippet_links": [], "samples": [{"hash": "3MZu6I6lBwk", "uri": "/contracts/3MZu6I6lBwk#initial-target", "label": "License and Option Agreement (Spark Therapeutics, Inc.)", "score": 28.1594791412, "published": true}, {"hash": "liqthmZPnfM", "uri": "/contracts/liqthmZPnfM#initial-target", "label": "License and Option Agreement (Selecta Biosciences Inc)", "score": 28.1211490631, "published": true}, {"hash": "8M0kcyiVCW4", "uri": "/contracts/8M0kcyiVCW4#initial-target", "label": "License and Option Agreement (Selecta Biosciences Inc)", "score": 27.9514026642, "published": true}], "size": 7, "hash": "c6a24f3c8e1862ca15831636890da724", "id": 2}, {"snippet": "means any of [**].", "snippet_links": [], "samples": [{"hash": "iMi8lfNULNA", "uri": "/contracts/iMi8lfNULNA#initial-target", "label": "Research Collaboration and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "2uEVDoPG5aV", "uri": "/contracts/2uEVDoPG5aV#initial-target", "label": "Research Collaboration and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "chpinkxbv8v", "uri": "/contracts/chpinkxbv8v#initial-target", "label": "Research Collaboration and License Agreement (Arvinas Holding Company, LLC)", "score": 29.7008895874, "published": true}], "size": 6, "hash": "864e53994566f1d4435c6925e07edd3a", "id": 3}, {"snippet": "means any of the Targets set forth in Exhibit 1.74 attached hereto.", "snippet_links": [{"key": "the-targets", "type": "clause", "offset": [13, 24]}], "samples": [{"hash": "gKH6Rukubqs", "uri": "/contracts/gKH6Rukubqs#initial-target", "label": "Option, License, and Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "eAharHezhsr", "uri": "/contracts/eAharHezhsr#initial-target", "label": "Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC)", "score": 29.7008895874, "published": true}, {"hash": "q4N0M9Xkus", "uri": "/contracts/q4N0M9Xkus#initial-target", "label": "Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC)", "score": 29.659822464, "published": true}], "size": 6, "hash": "84e940d062c15bd95de88dabda34b3e8", "id": 4}, {"snippet": "means [***].", "snippet_links": [], "samples": [{"hash": "acAoh0uRZzN", "uri": "/contracts/acAoh0uRZzN#initial-target", "label": "License and Collaboration Agreement (Molecular Partners Ag)", "score": 34.1827507019, "published": true}, {"hash": "h2Ke6zdhMmh", "uri": "/contracts/h2Ke6zdhMmh#initial-target", "label": "License and Collaboration Agreement (Molecular Partners Ag)", "score": 33.1998634338, "published": true}], "size": 6, "hash": "42145ccc68badf480a8ed917c57dd5fc", "id": 5}, {"snippet": "means KRAS.", "snippet_links": [], "samples": [{"hash": "jHT0QKey9ZU", "uri": "/contracts/jHT0QKey9ZU#initial-target", "label": "Research Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)", "score": 25.0766601562, "published": true}, {"hash": "bwt6xpH3DpL", "uri": "/contracts/bwt6xpH3DpL#initial-target", "label": "Research Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)", "score": 25.0739212036, "published": true}, {"hash": "7tMLOume5NX", "uri": "/contracts/7tMLOume5NX#initial-target", "label": "Research Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)", "score": 25.043806076, "published": true}], "size": 4, "hash": "85e19d897f598671d3c36d57702fcb16", "id": 6}, {"snippet": "means the Huntingtin gene, as defined by Gene ID [***] in the [***] GenBank, including [***].", "snippet_links": [], "samples": [{"hash": "4lSn29JCiEI", "uri": "/contracts/4lSn29JCiEI#initial-target", "label": "Collaboration and License Agreement (Sangamo Biosciences Inc)", "score": 26.8261470795, "published": true}, {"hash": "hakYY1TWU6n", "uri": "https://investor.sangamo.com/static-files/25049380-5938-4d1c-8ce0-9da66cdae783", "label": "investor.sangamo.com", "score": 9.9952087402, "published": false}, {"hash": "aSwSxMvlmb0", "uri": "https://investor.sangamo.com/static-files/837a1c09-0c3a-4367-8287-8b43290d710d", "label": "investor.sangamo.com", "score": 6.9835729599, "published": false}], "size": 3, "hash": "de17001ef44218bb3a74c9d66ee02650", "id": 7}, {"snippet": "means NY-ESO-1 restricted by HLA-A*0201;", "snippet_links": [], "samples": [{"hash": "icI8pNXGqh0", "uri": "/contracts/icI8pNXGqh0#initial-target", "label": "Collaboration and License Agreement (Adaptimmune Therapeutics PLC)", "score": 24.3169059753, "published": true}, {"hash": "jBfJcbWgcZv", "uri": "/contracts/jBfJcbWgcZv#initial-target", "label": "Collaboration and License Agreement (Adaptimmune Therapeutics PLC)", "score": 24.2594108582, "published": true}, {"hash": "hQjTX92SXX4", "uri": "/contracts/hQjTX92SXX4#initial-target", "label": "Collaboration and License Agreement (Adaptimmune LTD)", "score": 24.0951404572, "published": true}], "size": 3, "hash": "31fe9e3dcd3c8179fbdc0c12ef855870", "id": 8}, {"snippet": "means the Target referred to as IDUA (UniProt identification number P35475).", "snippet_links": [{"key": "the-target", "type": "clause", "offset": [6, 16]}, {"key": "identification-number", "type": "definition", "offset": [46, 67]}], "samples": [{"hash": "bSQ5oKQ0LWf", "uri": "/contracts/bSQ5oKQ0LWf#initial-target", "label": "Research and Collaboration Agreement (ProQR Therapeutics N.V.)", "score": 33.9746742249, "published": true}, {"hash": "b8Mb6HjAPBB", "uri": "/contracts/b8Mb6HjAPBB#initial-target", "label": "Research and Collaboration Agreement (ProQR Therapeutics N.V.)", "score": 32.6851463318, "published": true}, {"hash": "fzTCAFq5lu2", "uri": "http://pdf.secdatabase.com/1586/0001104659-21-113798.pdf", "label": "pdf.secdatabase.com", "score": 11.4914445877, "published": false}], "size": 3, "hash": "f22d0ffd31a00ae91277c218027d3e9f", "id": 9}, {"snippet": "means the first Target selected by MERSANA as of the Effective Date, identified as [***], with a common name of [***].", "snippet_links": [{"key": "first-target", "type": "definition", "offset": [10, 22]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [43, 67]}, {"key": "common-name", "type": "definition", "offset": [97, 108]}], "samples": [{"hash": "az0ORsWzciZ", "uri": "/contracts/az0ORsWzciZ#initial-target", "label": "Commercial License and Option Agreement (Mersana Therapeutics, Inc.)", "score": 29.5982208252, "published": true}, {"hash": "aBQQmEzE1Gj", "uri": "https://ir.mersana.com/static-files/873e699e-6a56-4c67-bb25-028f71f9d286", "label": "ir.mersana.com", "score": 10.2991104126, "published": false}], "size": 2, "hash": "9f1ae879d8a23ea27ecfa365b181118b", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIXaW5pdGlhbC10YXJnZXQjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "shall have the meaning set forth in Section 3.1 hereof.", "title": "Initial Target", "size": 76, "id": "initial-target", "examples": ["Additionally, during the Term, \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 may only recommend, and the Parties may only adopt, one change to the <strong>Initial Target</strong> pursuant to Section 3.4(b).", "Notwithstanding anything herein to the contrary, during the Term, \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 may only recommend, and the Parties may only adopt, one change to the <strong>Initial Target</strong> pursuant to Section 3.4(a).", "Upon so amending the Research Plan to include the Alternative Target, the <strong>Initial Target</strong> shall cease to be a Target."], "related": [["soft-target", "Soft Target", "Soft Target"], ["kpi-target", "KPI Target", "KPI Target"], ["m2-target-amount", "M2 Target Amount", "M2 Target Amount"], ["m1-target-amount", "M1 Target Amount", "M1 Target Amount"], ["m3-target-amount", "M3 Target Amount", "M3 Target Amount"]], "related_snippets": [], "updated": "2026-09-23T06:37:02+00:00"}, "json": true, "cursor": ""}}